Neurobiology of Depression and Novel Antidepressant Drug Targets

E-ISSN： 1873-4286|18|36|5791-5801

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.36, 2012-12, pp. : 5791-5801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidepressant therapy: new targets for drug development

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1693-1711

Informa Healthcare

Access to resources Recommend Favorite

The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 183-192

Bentham Science Publishers

Access to resources Recommend Favorite

Neurobiology of antidepressant treatments

By de Montigny C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 262-262

Elsevier

Access to resources Recommend Favorite

Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment

Current Neuropharmacology, Vol. 14, Iss. 7, 2016-08 ,pp. : 674-687

Bentham Science Publishers

Access to resources Recommend Favorite

Baseline severity of depression predicts antidepressant drug response relative to escitalopram

By Kilts Clinton D Wade Alan G Andersen Henning F Schlaepfer Thomas E

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 927-936

Informa Healthcare

Access to resources Recommend Favorite